menu search

Janone to present prior phase ii data on diabetic neuropathy at the ohio society of interventional pain physicians annual meeting

JAN101 Showed Statistically Significant Reduction in Pain and Improvement in Nerve Conduction Velocity in Prior ...

August 18, 2023, 12:42 pm

Akari therapeutics announces establishment of boston u.s. headquarters office to support expanding operations and start of registrational phase 3 clinical trials

NEW YORK and LONDON, Aug. 18, 2023 (GLOBE NEWSWIRE) — Akari Therapeutics, Plc (Nasdaq: AKTX), a late-stage biotechnology company developing advanced...

August 18, 2023, 12:00 pm

Usd/cad consolidates its recent gains to over a two-month high, around mid-1.3500s

The USD/CAD pair enters a bullish consolidation phase during the Asian session on Friday and oscillates...

August 18, 2023, 1:29 am

Strong financials and pipeline position vaxcyte for success

Vaxcyte, Inc. is a clinical-stage vaccine company developing high-fidelity vaccines for bacterial diseases. The company's Q2 2023 earnings report show...

August 17, 2023, 6:34 pm

Arry vs. enph: which stock is the better value option?

Investors interested in Solar stocks are likely familiar with Array Technologies, Inc. (ARRY) and Enphase ...

August 17, 2023, 1:17 pm

Processa pharmaceuticals provides data update supporting a potential personalized treatment approach for improved cancer care

Interim analysis of phase 1B data suggests Processa’s novel chemotherapy treatment could improve safe...

August 17, 2023, 12:05 pm

Marvel discovery launches ai-powered geophysical survey of saskatchewan uranium projects

Marvel Discovery Corp. (TSX-V:MARV) said it has kicked off a detailed regional and property-specific structural geophysical interpretation of its Sask...

August 17, 2023, 11:51 am

Excision biotherapeutics announces gene therapy publication of pre-clinical data supporting its first-in-class crispr-based gene therapy candidate designed to functionally cure hiv-1

Results demonstrate safety, biodistribution, and on-target editing of simian immunodeficiency virus (SIV) in non-human primates Data are a key compone...

August 17, 2023, 11:30 am

Cisco ceo chuck robbins on outlook: we are well-positioned for the next a.i. phase

Cisco CEO Chuck Robbins joins 'Squawk on the Street' to discuss the company's quarterly earnings results, full-year forecast, and more....

August 17, 2023, 10:36 am

There's a new kid on the crypto block. but will pyusd make a change?

Crypto has come a long way over the past decade, and if you had to define where in its history we are right now, one possible answer would be that we�...

August 17, 2023, 10:08 am

Bet on the ai gold rush's next phase with these 3 stocks

Companies utilize artificial intelligence (AI) in two primary ways. Many tech firms apply AI to enhance existing operations, including robotics, self-...

August 17, 2023, 9:13 am

Acme lithium completes 10-day pumping test at clayton vally lithium brine project

ACME Lithium Inc. (CSE:ACME, OTCQB:ACLHF) told investors it has successfully completed a 10-day pumping test at test well TW-1 at its Clayton Valley ...

August 17, 2023, 9:06 am

Immunic completes enrollment in trial of vidofludimus calcium in patients with progressive ms

Immunic Inc (NASDAQ:IMUX) said it has completed the enrollment of its phase 2 CALLIPER trial of lead a...

August 17, 2023, 8:19 am

Agios pharmaceuticals: positive phase 2 results in sickle cell study

Agios Pharmaceuticals is a biotech company focused on developing medicines for cancer and rare genetic diseases. The company's financials show growth,...

August 17, 2023, 5:14 am

Applied therapeutics: buy for upcoming pre-nda meeting (i expect a positive outcome)

Applied Therapeutics is a micro-cap with low cash balance, but has major upcoming catalysts (pre-NDA meeting for galactosemia and ...

August 17, 2023, 4:28 am

Crinetics pharmaceuticals: paltusotine phase 3 data presented at endo

Crinetics Pharmaceuticals has shown a significant increase in R&D and administrative expenses, leading to a widening net loss trajectory. The company'...

August 17, 2023, 3:43 am

Iq-ai to focus on the commercial potential of its software alongside phase i study

IQ-AI Ltd (LSE:IQAI, OTCQB:IQAIF) said it aims to convert a significant portion of the 45 sites currently assessing its IB imaging software into clien...

August 17, 2023, 3:06 am

Denison mines: the feasibility study demonstrates wheeler's potential

Denison's Wheeler River Project has a Reserve of 106.4Mlbs (P&P) of U3O8. The Phoenix phase will have s...

August 16, 2023, 5:15 pm

Foghorn therapeutics: ifs, buts, and clinical holds

Foghorn Therapeutics Inc. stock has increased by 70% in the last 4 months after a clinical hold on their lead program was lifted. Foghorn's technology...

August 16, 2023, 5:08 pm

Solid phase extraction market projected to reach us$ 11 billion by 2033 | fact.mr report

Rising Pollution Levels Driving Increased Adoption of SPE in Water Quality Management and Environmental Analysis Rockville, Aug. 16, 2023 (GLOBE NEWSW...

August 16, 2023, 4:00 pm


Search within

Pages Search Results: